StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.75−1.03 (-2.66%)

Close on Nov 18, 2026Market cap $3.66BP/E –Yield –

Xenon Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Xenon Pharmaceuticals's pe ratio was 7.3× on Oct 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Oct 30, 20157.3×+2.2
2014Dec 31, 20145.1×–

More Xenon Pharmaceuticals figures

See a number that looks wrong?